$14.615
-0.403 (-2.76%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
EUDA Prediction & Forecast by Similar Chart Analysis
Alphio's EUDA stock price prediction model matches the current EUDA Health Holdings Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $14.60 (-0.10%). The 1-week path is $14.44 (-1.23%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy EUDA Health Holdings Ltd Stock?
EUDA Health Holdings is currently not a strong buy due to its significant year-to-date decline of 70.29% and a negative EPS forecast of -9.46 for Q4 2024. Although the stock has seen a recent 5-day increase of 10.64%, it remains under pressure from compliance challenges and a low current ratio of 0.18, indicating liquidity issues. The main risk is the Nasdaq compliance deadline, as the company must achieve a market value of at least $35 million by October 20, 2026, to avoid delisting.
EUDA stock price ended at $14.62 on Friday, after losing -2.76%
EUDA Health Holdings Ltd (EUDA) last closed at $14.6154, losing -2.76%. These facts feed the 1-day and 1-week EUDA price prediction above.
Forecast Drivers
EUDA Health Holdings Ltd (EUDA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches EUDA, ranked by similarity.
Seasonality analysis for EUDA
Historically the probability of a positive August return for EUDA is 34.92%. November offers the highest probability of a positive month at 51.28%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.